Senior Manager, Late-Stage Oncology Clinical Development

Pfizer; United States; Hybrid; USD 139,000 - 232,000; Full time

Job summary

Pfizer is seeking a Clinical Development Expert for Late-Stage Oncology portfolios. You will oversee scientific aspects, ensure data integrity, and support development strategies across programs, while authoring essential regulatory and study documents.

You will partner with medical, regulatory, and operations teams to drive high-quality trials. Responsibilities include leading data review strategies, monitoring safety signals, and ensuring compliance with ICH/GCP and global regulations.

Qualifications

• PhD/PharmD with at least 2 years clinical research in industry/CRO
• MS with at least 5 years clinical research in industry/CRO
• BA/BS with at least 7 years clinical research in industry/CRO

Responsibilities

• Provide scientific oversight for clinical trials in the Late-Stage Oncology portfolio.
• Author protocols, study-level informed consent documents, and contribute to study reports and regulatory submissions.
• Set the clinical data review strategy and lead data quality reviews across emerging safety data and trends.
• Collaborate with cross-functional teams and regulatory stakeholders to support development strategy.
• Ensure compliance with ICH, GCP, and global regulatory requirements.

Skills

Clinical development

Data integrity

Regulatory submissions

Cross-functional leadership

Communication

Education

PhD/PharmD

MS in science

BA/BS in science

Tools

Microsoft Office

Job description

Pfizer is seeking a Clinical Development Expert for Late-Stage Oncology portfolios. You will oversee scientific aspects, ensure data integrity, and support development strategies across programs, while authoring essential regulatory and study documents.

You will partner with medical, regulatory, and operations teams to drive high-quality trials. Responsibilities include leading data review strategies, monitoring safety signals, and ensuring compliance with ICH/GCP and global regulations.